Photogallery. Pyoderma gangrenosum
- 作者: Grabovskaya O.V.1, Kusraeva D.T.1, Bobkova A.E.1
-
隶属关系:
- The First Sechenov Moscow State Medical University
- 期: 卷 28, 编号 1 (2025)
- 页面: 121-129
- 栏目: PHOTO GALLERY
- ##submission.dateSubmitted##: 23.11.2024
- ##submission.dateAccepted##: 14.02.2025
- ##submission.datePublished##: 06.05.2025
- URL: https://rjsvd.com/1560-9588/article/view/642191
- DOI: https://doi.org/10.17816/dv642191
- ID: 642191
如何引用文章
详细
Pyoderma gangrenosum is a rare autoinflammatory disease belonging to the group of neutrophilic dermatoses. It is characterized by the formation of painful, rapidly progressing ulcerative necrotic lesions with covered edges of a bluish hue and pronounced surrounding erythema. Despite its historical name, pyoderma gangrenosum is not gangrene or pyoderma, which highlights the complexity of its pathogenesis and clinical course.
The pathophysiology of the disease includes dysregulation of innate immunity, genetic mutations, and neutrophil dysfunction.
Pyoderma gangrenosum often develops against the background of somatic diseases. In more than half of patients, it is associated with inflammatory bowel diseases (Crohn's disease, ulcerative colitis), hematological disorders (myeloma, chronic lymphocytic leukemia), as well as rheumatological diseases (rheumatoid arthritis). This fact makes pyoderma gangrenosum an important interdisciplinary disease that requires an integrated approach to diagnosis and treatment.
Ulcerative lesions are mainly localized on the lower extremities, however, their occurrence is also possible on the trunk, upper extremities, face and scalp, which significantly complicates the diagnosis and differentiation with other skin diseases.
Diagnosis of the disease is based on clinical manifestations, exclusion of other causes of ulcerative necrotic lesions (infectious, vascular and other processes), as well as histological examination data revealing abundant neutrophil infiltration of the dermis and hypodermis. The treatment of pyoderma gangrenosum includes suppressive drugs and targeted therapy using genetically engineered biological drugs (GIBPS) aimed at controlling the inflammatory process. The approach to therapy is determined individually, depending on the severity of the course and the presence of concomitant diseases.
We present the variability of clinical manifestations of pyoderma gangrenosum in order to improve timely diagnosis and adequate treatment (from the archive of The First Sechenov Moscow State Medical University, the photographs are published for the first time with the permission of the institution's administration).
全文:

作者简介
Olga Grabovskaya
The First Sechenov Moscow State Medical University
编辑信件的主要联系方式.
Email: rjdv@eco-vector.com
ORCID iD: 0000-0002-5259-7481
俄罗斯联邦, Moscow
Diana Kusraeva
The First Sechenov Moscow State Medical University
Email: rjdv@eco-vector.com
ORCID iD: 0000-0002-5633-7986
俄罗斯联邦, Moscow
Anna Bobkova
The First Sechenov Moscow State Medical University
Email: rjdv@eco-vector.com
ORCID iD: 0000-0003-3611-0917
俄罗斯联邦, Moscow
参考
补充文件
